Mind Medicine (MindMed) Inc (Nasdaq: MNMD) will present preclinical data of MM-402, the Company’s proprietary form of the R-enantiomer of 3,4-Methylenedioxymethamphetamine (MDMA), in a model…
October 06, 2023
October 06, 2023
Orchard Therapeutics Acquired by Kyowa Kirin as Part of 2023 Vision to ‘Make People Smile’
Global gene therapy leader, Orchard Therapeutics (Nasdaq: ORTX), will be acquired by Kyowa Kirin in a deal valued at almost $390M. Kyowa Kirin (TSE: 4151)…
September 15, 2023
Horizon Therapeutics Doses First Patient in Alopecia Clinical Trial
Horizon Therapeutics plc (Nasdaq: HZNP) has dosed the first patient in a randomized, double-blind, placebo-controlled, Phase 2 multicenter, proof-of-concept study to evaluate bempikibart in adult…